[HTML][HTML] Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives
Background Alzheimer's disease (AD) is the most prevalent cause of cognitive impairment
and dementia worldwide. The pathobiology of the disease has been studied in the form of …
and dementia worldwide. The pathobiology of the disease has been studied in the form of …
Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives
KD Fasae, AO Abolaji, TR Faloye… - Journal of Trace …, 2021 - ui.adsabs.harvard.edu
Hypotheses for the pathogenesis of Alzheimer's disease (AD) were described. Metal-based
hypothesis in neurodegeneration is strategic to identifying therapeutic alternatives for AD …
hypothesis in neurodegeneration is strategic to identifying therapeutic alternatives for AD …
Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives
KD Fasae, AO Abolaji, TR Faloye… - Journal of trace …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Alzheimer's disease (AD) is the most prevalent cause of cognitive impairment
and dementia worldwide. The pathobiology of the disease has been studied in the form of …
and dementia worldwide. The pathobiology of the disease has been studied in the form of …
[引用][C] Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives
KD Fasae, AO Abolaji, TR Faloye, AY Odunsi… - Journal of Trace …, 2021 - cir.nii.ac.jp
Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer’s
disease: Limitations, and current and future perspectives | CiNii Research CiNii 国立情報学 …
disease: Limitations, and current and future perspectives | CiNii Research CiNii 国立情報学 …
Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives
KD Fasae, AO Abolaji, TR Faloye… - Journal of Trace …, 2021 - einstein.elsevierpure.com
Background: Alzheimer's disease (AD) is the most prevalent cause of cognitive impairment
and dementia worldwide. The pathobiology of the disease has been studied in the form of …
and dementia worldwide. The pathobiology of the disease has been studied in the form of …
Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: limitations, and current and future perspectives.
KD Fasae, AO Abolaji, TR Faloye, AY Odunsi… - 2021 - cabidigitallibrary.org
Background: Alzheimer's disease (AD) is the most prevalent cause of cognitive impairment
and dementia worldwide. The pathobiology of the disease has been studied in the form of …
and dementia worldwide. The pathobiology of the disease has been studied in the form of …
[PDF][PDF] Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives
KD Fasae, AO Abolaji, TR Faloye… - Journal of Trace …, 2021 - academia.edu
Background: Alzheimer's disease (AD) is the most prevalent cause of cognitive impairment
and dementia worldwide. The pathobiology of the disease has been studied in the form of …
and dementia worldwide. The pathobiology of the disease has been studied in the form of …
Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
KD Fasae, AO Abolaji, TR Faloye… - Journal of Trace …, 2021 - europepmc.org
Background Alzheimer's disease (AD) is the most prevalent cause of cognitive impairment
and dementia worldwide. The pathobiology of the disease has been studied in the form of …
and dementia worldwide. The pathobiology of the disease has been studied in the form of …